Wednesday, September 27, 2006

Indian Court All Set for Gleevec Case

On September 26, 2006 a Chennai High Court Judge has ruled that patent dispute over the anti-leukemia drug Gleevec should be heard by a two-judge panel, contending that the importance of the questions involved required a larger panel. The ruling came as setback to aid groups, which wanted the case to be dismissed by the judge. Novartis, which is challenging the Patent Office decision back in January 2006 to reject its patent application for Gleevec and seeking review by the Chennai High Court, has subsequently challenged the constitutional validity of section 3 (d) contending that section 3(d) of the Patents Act 1970 is not TRIPS compliant.

No comments:

Post a Comment